Gastroenterology
Volume 134, Issue 7 , Pages 1981-1993 , June 2008

The Essential Role of Fibroblasts in Esophageal Squamous Cell Carcinoma–Induced Angiogenesis

  • Kazuhiro Noma

      Affiliations

    • The Wistar Institute, Philadelphia, Pennsylvania
    • ,
  • Keiran S.M. Smalley

      Affiliations

    • The Wistar Institute, Philadelphia, Pennsylvania
    • ,
  • Mercedes Lioni

      Affiliations

    • The Wistar Institute, Philadelphia, Pennsylvania
    • ,
  • Yoshio Naomoto

      Affiliations

    • Departments of Gastroenterological Surgery, Transplant and Surgical Oncology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
    • ,
  • Noriaki Tanaka

      Affiliations

    • Departments of Gastroenterological Surgery, Transplant and Surgical Oncology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
    • ,
  • Wafik El–Deiry

      Affiliations

    • Hematology-Oncology Division, Department of Medicine, Department of Genetics, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Alastair J. King

      Affiliations

    • GlaxoSmithKline, Collegeville, Pennsylvania
    • ,
  • Hiroshi Nakagawa

      Affiliations

    • Gastroenterology Division, Department of Medicine, Department of Genetics, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Meenhard Herlyn

      Affiliations

    • The Wistar Institute, Philadelphia, Pennsylvania
    • Corresponding Author InformationAddress requests for reprints to: Meenhard Herlyn, DVM, or Keiran S. M. Smalley, PhD, The Wistar Institute, 3601 Spruce Street, Philadelphia, Pennsylvania 19104.

Received 17 January 2008 ,Accepted 19 February 2008.

References 

  1. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer. 2001;1:46–54
  2. Dvorak HF. Tumors: wounds that do not heal (Similarities between tumor stroma generation and wound healing). N Engl J Med. 1986;315:1650–1659
  3. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res. 2001;264:169–184
  4. Nakayama H, Enzan H, Miyazaki E, et al. The role of myofibroblasts at the tumor border of invasive colorectal adenocarcinomas. Jpn J Clin Oncol. 1998;28:615–620
  5. Tsukamoto H, Mishima Y, Hayashibe K, et al. Alpha-smooth muscle actin expression in tumor and stromal cells of benign and malignant human pigment cell tumors. J Invest Dermatol. 1992;98:116–120
  6. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol. 2003;200:429–447
  7. Direkze NC, Hodivala-Dilke K, Jeffery R, et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 2004;64:8492–8495
  8. Sappino AP, Skalli O, Jackson B, et al. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer. 1988;41:707–712
  9. De Wever O, Nguyen QD, Van Hoorde L, et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent proinvasive signals to human colon cancer cells through RhoA and Rac. FASEB J. 2004;18:1016–1018
  10. Fukumura D, Xavier R, Sugiura T, et al. Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998;94:715–725
  11. Lioni M, Brafford P, Andl C, et al. Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol. 2007;170:709–721
  12. Andl CD, Mizushima T, Nakagawa H, et al. Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem. 2003;278:1824–1830
  13. Velazquez OC, Snyder R, Liu ZJ, et al. Fibroblast-dependent differentiation of human microvascular endothelial cells into capillary-like, three-dimensional networks. FASEB J. 2002;16:1316–1318
  14. Smalley KS, Contractor R, Haass NK, et al. Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels. Br J Cancer. 2007;96:445–449
  15. Orimo A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle. 2006;5:1597–1601
  16. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6:392–401
  17. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121:335–348
  18. Levy L, Hill CS. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 2006;17:41–58
  19. Tanaka S, Mori M, Mafune K, et al. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma. Br J Cancer. 2000;82:1557–1560
  20. Garrigue-Antar L, Souza RF, Vellucci VF, et al. Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer. Lab Invest. 1996;75:263–272
  21. Fukai Y, Fukuchi M, Masuda N, et al. Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Int J Cancer. 2003;104:161–166
  22. DaCosta Byfield S, Major C, Laping NJ, et al. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2004;65:744–752
  23. Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029–1039
  24. Dong J, Grunstein J, Tejada M, et al. VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis. EMBO J. 2004;23:2800–2810
  25. Hlatky L, Tsionou C, Hahnfeldt P, et al. Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res. 1994;54:6083–6086
  26. Nakagawa T, Lan HY, Zhu HJ, et al. Differential regulation of VEGF by TGF-beta and hypoxia in rat proximal tubular cells. Am J Physiol Renal Physiol. 2004;287:F658–F664
  27. Kobayashi T, Liu X, Wen FQ, et al. Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts. Biochem Biophys Res Commun. 2005;327:393–398
  28. Renner U, Lohrer P, Schaaf L, et al. Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells. Endocrinology. 2002;143:3759–3765
  29. Ito TK, Ishii G, Chiba H, et al. The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene. 2007;26:7194–7203
  30. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307:58–62

 Supported by National Cancer Institute grant P01-CA098101 (to M.H.).The authors declare no financial conflicts of interest.

PII: S0016-5085(08)00299-0

doi: 10.1053/j.gastro.2008.02.061

Gastroenterology
Volume 134, Issue 7 , Pages 1981-1993 , June 2008

Article Tools

* Image Usage & Resolution